These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 11751447

  • 1. The steroid 5alpha-reductase type II TA repeat polymorphism is not associated with risk of breast or ovarian cancer in Australian women.
    Spurdle AB, Hopper JL, Chen X, Dite GS, McCredie MR, Giles GG, Venter DJ, Southey MC, Purdie DM, Chenevix-Trench G.
    Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1287-93. PubMed ID: 11751447
    [Abstract] [Full Text] [Related]

  • 2. TA repeat polymorphism of the 5alpha-reductase gene and breast cancer.
    Bharaj B, Scorilas A, Giai M, Diamandis EP.
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):387-93. PubMed ID: 10794483
    [Abstract] [Full Text] [Related]

  • 3. Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study.
    Hsing AW, Chen C, Chokkalingam AP, Gao YT, Dightman DA, Nguyen HT, Deng J, Cheng J, Sesterhenn IA, Mostofi FK, Stanczyk FZ, Reichardt JK.
    Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1077-82. PubMed ID: 11588134
    [Abstract] [Full Text] [Related]

  • 4. The V89L polymorphism in the 5-alpha-reductase type 2 gene and risk of breast cancer.
    van Gils CH, Onland-Moret NC, Roest M, van Noord PA, Peeters PH.
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1194-9. PubMed ID: 14652280
    [Abstract] [Full Text] [Related]

  • 5. The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women.
    Spurdle AB, Hopper JL, Chen X, McCredie MR, Giles GG, Venter DJ, Southey MC, Chenevix-Trench G.
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):439-43. PubMed ID: 12010857
    [Abstract] [Full Text] [Related]

  • 6. Codon 89 polymorphism in the human 5 alpha-reductase gene in primary breast cancer.
    Scorilas A, Bharaj B, Giai M, Diamandis EP.
    Br J Cancer; 2001 Mar 23; 84(6):760-7. PubMed ID: 11259089
    [Abstract] [Full Text] [Related]

  • 7. Double-strand break repair gene polymorphisms and risk of breast or ovarian cancer.
    Webb PM, Hopper JL, Newman B, Chen X, Kelemen L, Giles GG, Southey MC, Chenevix-Trench G, Spurdle AB.
    Cancer Epidemiol Biomarkers Prev; 2005 Feb 23; 14(2):319-23. PubMed ID: 15734952
    [Abstract] [Full Text] [Related]

  • 8. Association among polymorphisms in the steroid 5alpha-reductase type II (SRD5A2) gene, prostate cancer risk, and pathologic characteristics of prostate tumors in an Ecuadorian population.
    Paz-y-Miño C, Witte T, Robles P, Llumipanta W, Díaz M, Arévalo M.
    Cancer Genet Cytogenet; 2009 Mar 23; 189(2):71-6. PubMed ID: 19215786
    [Abstract] [Full Text] [Related]

  • 9. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.
    Shu XO, Cai Q, Gao YT, Wen W, Jin F, Zheng W.
    Cancer Epidemiol Biomarkers Prev; 2003 Dec 23; 12(12):1462-7. PubMed ID: 14693738
    [Abstract] [Full Text] [Related]

  • 10. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
    Singh V, Rastogi N, Sinha A, Kumar A, Mathur N, Singh MP.
    Breast Cancer Res Treat; 2007 Jan 23; 101(1):73-81. PubMed ID: 16807674
    [Abstract] [Full Text] [Related]

  • 11. The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years.
    Spurdle AB, Hopper JL, Chen X, Dite GS, Cui J, McCredie MR, Giles GG, Ellis-Steinborner S, Venter DJ, Newman B, Southey MC, Chenevix-Trench G.
    Cancer Epidemiol Biomarkers Prev; 2002 Apr 23; 11(4):413-6. PubMed ID: 11927503
    [Abstract] [Full Text] [Related]

  • 12. The AIB1 glutamine repeat polymorphism is not associated with risk of breast cancer before age 40 years in Australian women.
    Montgomery KG, Chang JH, Gertig DM, Dite GS, McCredie MR, Giles GG, Southey MC, Hopper JL, Campbell IG.
    Breast Cancer Res; 2005 Apr 23; 7(3):R353-6. PubMed ID: 15987430
    [Abstract] [Full Text] [Related]

  • 13. V89L polymorphism of the 5alpha-reductase Type II gene (SRD5A2), endogenous sex hormones, and prostate cancer risk.
    Boger-Megiddo I, Weiss NS, Barnett MJ, Goodman GE, Chen C.
    Cancer Epidemiol Biomarkers Prev; 2008 Feb 23; 17(2):286-91. PubMed ID: 18268111
    [Abstract] [Full Text] [Related]

  • 14. Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk.
    Zheng W, Xie D, Cerhan JR, Sellers TA, Wen W, Folsom AR.
    Cancer Epidemiol Biomarkers Prev; 2001 Feb 23; 10(2):89-94. PubMed ID: 11219777
    [Abstract] [Full Text] [Related]

  • 15. Microsatellite profile in hormonal receptor genes associated with breast cancer.
    Iobagiu C, Lambert C, Normand M, Genin C.
    Breast Cancer Res Treat; 2006 Jan 23; 95(2):153-9. PubMed ID: 16317584
    [Abstract] [Full Text] [Related]

  • 16. P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer.
    Naidu R, Har YC, Taib NA.
    J Exp Clin Cancer Res; 2007 Mar 23; 26(1):133-40. PubMed ID: 17550142
    [Abstract] [Full Text] [Related]

  • 17. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
    Lose F, Duffy DL, Kay GF, Kedda MA, Spurdle AB, Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Australian Ovarian Cancer Study Management Group.
    J Natl Cancer Inst; 2008 Nov 05; 100(21):1519-29. PubMed ID: 18957670
    [Abstract] [Full Text] [Related]

  • 18. The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study.
    Haiman CA, Brown M, Hankinson SE, Spiegelman D, Colditz GA, Willett WC, Kantoff PW, Hunter DJ.
    Cancer Res; 2002 Feb 15; 62(4):1045-9. PubMed ID: 11861380
    [Abstract] [Full Text] [Related]

  • 19. [Study on serum organochlorines pesticides (DDTs) level, CYP1A1 genetic polymorphism and risk of breast cancer: a case control study].
    Li JY, Wu DS, Yang F, Zeng HY, Lei FM, Zhou WD, Li H, Tao P.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Mar 15; 27(3):217-22. PubMed ID: 16792888
    [Abstract] [Full Text] [Related]

  • 20. Associations between polymorphisms in the steroid 5-alpha reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer.
    Salam MT, Ursin G, Skinner EC, Dessissa T, Reichardt JK.
    Urol Oncol; 2005 Mar 15; 23(4):246-53. PubMed ID: 16018939
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.